AUCTA宣布其氨己烯酸散剂在中国与复星医药签署上市销售许可
July 25, 2019 00:01 ET
|
Aucta Pharmaceuticals, Inc.
新泽西州，皮斯卡塔韦, July 25, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc.（Aucta）是一家专注从事品牌专业产品开发 与商业化的科技企业。近日，该公司宣布已与 上海复星医药（集团）股份有限公司（以下称“复星医药”）控股子公司江苏万邦生化医...
AUCTA宣布其氨己烯酸散劑在中國與復星醫藥簽署上市銷售許可
July 25, 2019 00:01 ET
|
Aucta Pharmaceuticals, Inc.
新澤西州，皮斯卡塔韋, July 25, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc.（Aucta）是一家專注從事品牌專業產品開發 與商業化的科技企業。近日，該公司今天宣布已與上海復星醫藥（集團）股份有限公司（以下稱“復星醫藥”）下屬的控股子公司江蘇萬 邦生化醫藥股份有限公司簽署排他性許可協議（以下稱“協議”） ...
Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution in China
July 25, 2019 00:01 ET
|
Aucta Pharmaceuticals, Inc.
PISCATAWAY, N.J., July 25, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta), a technology based company focusing on the development and commercialization of Branded Specialty Products,...
Aucta Pharmaceuticals宣布就拉莫三嗪新药申请授予许可
June 27, 2019 08:00 ET
|
Aucta Pharmaceuticals, Inc.
新泽西州PISCATAWAY, June 27, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta)是一家拥有特有技术平台的产品公司，公司致力于专科领域品牌产品的研发和商业化。该公司今天宣布已与Eton Pharmaceuticals, Inc.签订协议，将AUC025在美国市场的销售权给予Eton...
Aucta Pharmaceuticals 宣佈就拉莫三嗪新藥申請授予許可
June 27, 2019 08:00 ET
|
Aucta Pharmaceuticals, Inc.
新澤西州，PISCATAWAY, June 27, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta)是一家擁有特有技術平臺的產品公司，公司致力於專科領域品牌產品的研發和商業化。該公司今天宣佈已與Eton Pharmaceuticals, Inc.簽訂協定，將AUC025在美國市場的銷售權給予Eton...
Aucta Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application
June 27, 2019 08:00 ET
|
Aucta Pharmaceuticals, Inc.
PISCATAWAY, N.J., June 27, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta), a technology based company focusing on the development and commercialization of Branded Specialty Products,...
Aucta Pharmaceuticals及Oakrum Pharma宣佈將進行產品開發和商業化合作
February 19, 2019 08:00 ET
|
Aucta Pharmaceuticals, Inc.
美國新澤西州北布倫瑞克, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta) 今天宣佈其已與Oakrum Pharma, LLC (Oakrum) 達成一項協議，將開發並生產四種擬在美國以Oakrum商標進行商業化的處方仿製藥產品。 預計這些產品將供應予零售市場，包括口服液和局部用藥。...
Aucta Pharmaceuticals和Oakrum Pharma宣布将进行产品开发和商业化合作
February 19, 2019 08:00 ET
|
Aucta Pharmaceuticals, Inc.
北布伦瑞克,新泽西州, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc.（Aucta）今天宣布其已与Oakrum Pharma,...
Aucta Pharmaceuticals and Oakrum Pharma Announce Product Development and Commercialization Partnership
February 19, 2019 08:00 ET
|
Aucta Pharmaceuticals, Inc.
NORTH BRUNSWICK, N.J., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta) announced today that it has entered into an agreement with Oakrum Pharma, LLC (Oakrum) to develop and...
奥科达 获得首个产品批准并以Vigadrone™品牌推出氨己烯酸口服溶液用粉剂
July 16, 2018 08:00 ET
|
Aucta Pharmaceuticals, Inc.
新不伦瑞克省、新泽西州, July 16, 2018 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. （奥科达） 于今日宣布其递交的简略 新药申请获得美国食品药品监督管理局最终批准后，公司已经开始运输500 mg氨己烯酸口服溶液用粉剂产品。奥科达的商业合作伙伴 Upsher-Smith Laboratories, LLC...